Please ensure Javascript is enabled for purposes of website accessibility
Taylor Carmichael

Taylor Carmichael


Taylor Carmichael is a former attorney and filmmaker. He's the author of a line of murder mysteries, including Whodidit in the Supreme Court? and Whodidit With a Senator? The majority of what he knows about stocks he learned right here at the Motley Fool.

Recent articles


Why Is Everyone Talking About OPKO Health Stock?

The pharmaceutical and diagnostics specialist ran into some SEC-related controversy in 2018; now, it's a major player in the fight against COVID-19.


2 Marijuana Stocks That Could Be Millionaire Makers

Innovative Industrial Properties and Planet 13 have the potential to be big winners.


3 Top Restaurant Stocks to Buy in April

Here are two steak houses and a dominant chicken wing franchise for investors to bite into.


Immunomedics Halts Phase 3 Trial of Breast Cancer Drug Because of Compelling Efficacy

Sacituzumab govitecan has proven effective against triple-negative breast cancer.


2 Stocks to Get You Started Investing in 2020

Are you ready to jump in and make your first stock purchases. Here are some tips.


2 Top Stocks That Aren't On Wall Street's Radar

Adaptive Biotechnologies and Axsome Therapeutics are under-followed stocks with large upsides.


Why Did Amarin's Stock Fall Off a Cliff?

Amarin's stock dropped 70% after its patent for Vascepa was invalidated by a federal judge.


3 High-Growth Stocks That Could Soar

When the world recovers from the COVID-19 pandemic, these three stocks should rebound first.


Axsome Therapeutics' Key Drug Candidate Whiffs in Phase 3 Trial

The company's depression drug AXS-05 failed to meet its primary endpoints in the study, although it did hit the secondary endpoints.

Asset 5-100

About to Buy Penny Stocks? Look at These 3 Companies First

Here are three stocks that are all down over 60% thanks to COVID-19. Will they bounce back?


SmileDirectClub Will Start Making Face Shields for Doctors and Nurses

To help out during the COVID-19 pandemic, the teeth-straightening specialist will devote some of its 3-D printers to making protective gear for medical professionals.


Novavax Gets a Big Win for Its Flu Vaccine in Phase 3 Trial

After the biotech company needed a 1-for-20 reverse stock split last year to avoid being delisted, Novavax has hit a home run with NanoFlu.


My Top 7 Stocks to Buy in March's Stock Market Crash

Some amazing stocks are on sale right now.


FDA Issues Guidance for Clinical Trials During COVID-19 Pandemic

Efforts to stem the coronavirus outbreak are liable to disrupt the protocols of a lot of drug trials.


3 Stocks to Buy After the Coronavirus Crash

These companies should bounce back strong when the market finally recovers from the panic over COVID-19.


2 Winning Stocks to Buy in the Coronavirus Panic

While the spread of COVID-19 has destroyed billions of dollars of market value, stocks in healthcare companies that are fighting the virus continue to advance.


Regeneron and Sanofi Start Human Trials of Arthritis Drug as Possible COVID-19 Treatment

Kevzara is being tested in a phase 2/3 trial to see if it's effective against the novel coronavirus.


Teladoc Health Reports 50% Spike in Daily Patient Visits

The telemedicine leader's stock is up 53% so far in 2020.


Under Questioning, CDC Director Agrees To Provide Free Testing for COVID-19, Regardless Of Insurance

While testifying before Congress, CDC chief Dr. Robert Redfield confirmed his agency will pay for COVID-19 testing on people without insurance.


Why Arrowhead Pharmaceuticals Shares Dropped 15% in February

After a stellar 2019, the biotech stock has lost 47% so far in 2020.